CMA costs case improves access to justice
The UK Supreme Court ruling involving Pfizer and Flynn is important for any company considering an appeal against the regulator, say Sophie Lawrance and James Batsford of Bristows.
Latest news
Japanese pharma company wins arbitration over cancer drug
16-08-2022
Dispute over the Enhertu began in 2019 | Antibody drug conjugate tech at issue | American Arbitration Association issued final decision.
Hemp group in cybersquatting clash
11-08-2022
Regions
Sectors
